Sanofi (SNY) Change in Accured Expenses (2009 - 2015)

Sanofi has disclosed Change in Accured Expenses across 6 years of filings, most recently posting $13.5 billion for Q2 2015.

• Change in Accured Expenses for Q2 2015 came in at $13.5 billion, up 4.4% year-over-year; the trailing twelve-month figure through Jun 2015 was $13.5 billion (up 4.4% YoY), and the FY2014 annual result was $15.1 billion, up 16.91% from the prior year.
• Change in Accured Expenses came in at $13.5 billion for Q2 2015 at Sanofi, down from $14.2 billion in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $14.2 billion in Q4 2014 to a low of $12.9 billion in Q4 2012.
• The 4-year median for Change in Accured Expenses is $13.2 billion (2013), against an average of $13.3 billion.
• Across the five-year window, Change in Accured Expenses climbed 2.63% in 2013 and increased 7.26% in 2014, its largest moves.
• Sanofi's Change in Accured Expenses stood at $12.9 billion in 2012, then rose by 2.63% to $13.2 billion in 2013, then gained by 7.26% to $14.2 billion in 2014, then fell by 5.13% to $13.5 billion in 2015.
• The last three Change in Accured Expenses figures came in at $13.5 billion (Q2 2015), $14.2 billion (Q4 2014), and $12.9 billion (Q2 2014), per Business Quant data.